Your visceral reaction to a simple request to tone it down indicates you are a very insecure person. You and your Ouija board buddy should trade emails and converse with each other privately instead of using this board for exchanging messages.
Twice, the stock has been trying to get through 30, and the Ouija board readers have been shorting it. It will close in the 30's today, and the shorts will get burnt.
The European Commission has granted approval to Merck's Keytruda, or pembrolizumab, as a treatment for advanced melanoma. The approval was backed by trial data that showed the drug reduced patients' death risk by 37% and improved one-year survival, compared with Bristol-Myers Squibb's Yervoy, or ipilimumab. PharmaTimes (U.K.) (7/22)
Jameson will not allow that. The Board will not allow that. DJ is collecting $800,000 for posting losses quarter after quarter. The guy has no credibility. He will be booted out immediately if the company is taken over.
Thanks for posting useful information. That was very enlightening reading. This post is of relevance unlike the many repeated useless ones on this board.
yadi yadi yada! Market is up 250 points, DVAX in the mud. Isac, when are going to cover your shorts?
Isaac has been on this board only a few months. He has posted about 300 messages in three months about the same thing over and over like a used car salesman. He does not understand statistics.
There is a strong negative correlation between your posts and the stock price. You must be a short!
Isaac, this incessant pumping - what is the reason for it? This information has been out there for a while. Biotech is high tech and quite different from selling used cars. Get over it. You know nothing more than any others on this board.
Don't count on it. Over 23 close today. Once the news stream starts there will be more. Bigger catalyst than TA.